NASDAQ:NH NantHealth (NH) Stock Price, News & Analysis → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free NH Stock Alerts $1.45 -0.34 (-18.99%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$1.15▼$1.7650-Day Range$0.29▼$1.7952-Week Range$1.24▼$9.75Volume40,099 shsAverage Volume38,073 shsMarket Capitalization$11.17 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaSustainability Get NantHealth alerts: Email Address Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. About NantHealth Stock (NASDAQ:NH)NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.Read More NH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NH Stock News HeadlinesMay 2, 2024 | americanbankingnews.comStockNews.com Begins Coverage on NantHealth (NASDAQ:NH)April 23, 2024 | travel.usnews.com13 Most Romantic Getaways in New HampshireMay 5, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.April 23, 2024 | businesswire.comNantHealth Welcomes Marc Harrison as Chief Legal Officer to Executive TeamApril 10, 2024 | finance.yahoo.comNantHealth Strengthens Product Leadership Team to Drive Innovation in Healthcare TechnologyApril 10, 2024 | businesswire.comNantHealth Strengthens Product Leadership Team to Drive Innovation in Healthcare TechnologyFebruary 18, 2024 | usatoday.comWill Nikki Haley give Donald Trump a run for his money in one-of-a-kind NH primary?January 21, 2024 | usnews.comWhat to Know About New Hampshire Before the PrimaryMay 5, 2024 | Paradigm Press (Ad)Never use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...January 6, 2024 | nypost.comNikki Haley slammed after saying NH voters ‘correct’ Iowa resultsJanuary 5, 2024 | foxnews.comFather of slain New Hampshire girl orchestrated savage plot to hide heinous crime: prosecutorsDecember 27, 2023 | nypost.comChris Christie’s time, temper grows short in New HampshireDecember 15, 2023 | usnews.comBest New Hampshire High SchoolsNovember 24, 2023 | usatoday.comRon DeSantis slipping: Falls further behind Donald Trump and Nikki Haley in New HampshireNovember 24, 2023 | usatoday.comNH schedules its first-in-the nation primary, despite an ongoing battle with DemocratsNovember 22, 2023 | theguardian.comGunman in fatal New Hampshire hospital shooting identifiedNovember 21, 2023 | theguardian.comNew Hampshire police yet to identify suspect in fatal hospital shootingNovember 7, 2023 | usatoday.comNikki Haley is making Vivek Ramaswamy her foreign policy foil. And New Hampshire voters are into it.October 24, 2023 | usatoday.comNikki Haley tells N.H. voters why Trump shouldn't be the president: 'Leave the negativity and chaos'October 18, 2023 | usatoday.comNew Hampshire debate watchers have a message for Chris Christie: Get off the island - PollOctober 14, 2023 | cbsnews.comRon DeSantis to file for New Hampshire primary ThursdayOctober 12, 2023 | usatoday.comPilot identified in fatal Croydon, New Hampshire helicopter crashSeptember 7, 2023 | usatoday.comMom drowns while trying to save her 10-year-old son at Franconia Falls in New HampshireSeptember 7, 2023 | usatoday.comMan drowns trying to rescue wife, her son in fast-moving New Hampshire riverSeptember 6, 2023 | foxnews.comNew Hampshire Democrats defy Biden, DNC ultimatum to ditch first-in-nation primary: 'embarrassing situation'August 26, 2023 | foxnews.comNew Hampshire sheriff placed on paid administrative leave after being accused of stealing county fundsAugust 24, 2023 | usatoday.comChris Christie pulls ahead of Ron DeSantis in New Hampshire, ranking second place for GOP: PollSee More Headlines Receive NH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today5/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Data processing & preparation Sub-IndustryN/A Current SymbolNASDAQ:NH Previous SymbolNYSE:NH CUSIPN/A CIK1566469 Webwww.nanthealth.com Phone(855) 949-6268FaxN/AEmployees326Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($7.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-67,780,000.00 Net Margins-94.67% Pretax Margin-95.06% Return on EquityN/A Return on Assets-39.82% Debt Debt-to-Equity RatioN/A Current Ratio0.64 Quick Ratio0.64 Sales & Book Value Annual Sales$67.68 million Price / Sales0.17 Cash FlowN/A Price / Cash FlowN/A Book Value($30.72) per share Price / Book-0.05Miscellaneous Outstanding Shares7,703,000Free Float2,981,000Market Cap$11.17 million OptionableNot Optionable Beta1.82 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesR. Harris NaseemChief Executive Officer & DirectorBob PetrouChief Financial OfficerTiffany AveryChief Medical OfficerBrandon VillerySecretary, Senior Vice President & General CounselRonald Allen LouksChief Strategy & Development OfficerKey CompetitorsShinecoNASDAQ:SISIAlzamend NeuroNASDAQ:ALZNBIOLASENASDAQ:BIOLCingulateNASDAQ:CINGOragenicsNYSE:OGENView All Competitors NH Stock Analysis - Frequently Asked Questions How have NH shares performed in 2024? NantHealth's stock was trading at $0.43 at the start of the year. Since then, NH shares have increased by 237.2% and is now trading at $1.45. View the best growth stocks for 2024 here. How were NantHealth's earnings last quarter? NantHealth, Inc. (NASDAQ:NH) announced its quarterly earnings data on Thursday, November, 4th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.02. The company earned $14.36 million during the quarter, compared to the consensus estimate of $17.70 million. During the same period in the previous year, the firm posted ($0.08) earnings per share. What is Patrick Soon-Shiong's approval rating as NantHealth's CEO? 82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of NantHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX). When did NantHealth IPO? NantHealth (NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers. How do I buy shares of NantHealth? Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NH) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
